Postoperative Adjuvant Therapy for Pancreatic Cancer

Seminars in Surgical Oncology

Volumn 21, Issue 4, 2003, Pages 256-260

  Penberthy, David R ^a   Rich, Tyvin A ^a   Adams, Reid B ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Adjuvant chemoradiation; Pancreas cancer; Post operative

Indexed keywords

FLUOROURACIL;

CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; HISTOPATHOLOGY; HUMAN; KIDNEY; LIVER METASTASIS; LYMPH NODE METASTASIS; PANCREAS CARCINOMA; PERITONEUM METASTASIS; PORTAL VEIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIOSENSITIZATION; REVIEW; SMALL INTESTINE; SPINAL CORD; STOMACH; SUPERIOR MESENTERIC ARTERY; SURGICAL TECHNIQUE; TREATMENT FAILURE;

CHEMOTHERAPY, ADJUVANT; HUMANS; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 0346123214     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.10044     Document Type: Review

References (14)

1. Whittington R, Bryer MP, Haller DG, et al: Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1991;21:1137-1143.
2. Bosset JF, Pavy JJ, Gillet M, et al: Conventional external irradiationalone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study. Radiother Oncol 1992;24:191-194.
3. Foo ML, Gunderson LL: Adjuvant postoperative radiation therapy +/-5-FU in resected carcinoma of the pancreas. Hepatogastroenterology 1998;45:613-623.
4. Yeo CJ, Cameron JL, Lillemoe KD, et al: Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;721-731.
5. Spitz FR, Abbruzzese JL, Lee JE, et al: Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928-937.
6. Poen JC, Ford JM, Niederhuber JE: Chemoradiotherapy in the management of localized tumors of the pancreas. Ann Surg Oncol 1999;6:117-122.
7. Mehta VK, Fisher GA, Ford JM, et al: Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer. Int J Radiat Oncol Biol Phys 2000;48:1483-1487.
8. Regine WF, John WJ, Mohiuddin M: Adjuvant therapy for pancreatic cancer: current status. Front Biosci 1998;3:E186-E192.
9. Penberthy DR, Rich TA, Shelton CH III, et al: A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer. Ann Oncol 2001;12:681-684.
10. Ceha HM, van Tienhoven G, Gouma DJ, et al: Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer 2000;89:2222-2229.
11. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-2010.
12. Klinkenbijl JH, Jeekel J, Sahmoud T, et al: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-782.
13. Bakkevold KE, Arnesjo B, Dahl O, Kambestad B: Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-results of a controlled, prospective, randomised multicentre study. Eur J Cancer 1993;29A:698-703.
14. Neoptolemos JP, Dunn JA, Stocken DD, et al: Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001;358(9293): 1576-1585.